Why does menopause cause vaginal dryness?

Detailed Explanation

Vaginal dryness is one of the most common and persistent symptoms of the menopause transition, yet it remains significantly under-reported and undertreated. Unlike hot flashes, which typically subside over time, vaginal changes driven by estrogen loss are progressive and rarely resolve without intervention. Understanding the biological mechanism behind this shift is essential for effective long-term management.

The vaginal walls are highly estrogen-dependent. During the reproductive years, high levels of circulating estrogen ensure that the vaginal epithelium (the lining) remains thick, moist, and elastic. Estrogen stimulates blood flow to the pelvic region, promotes the production of natural lubrication, and maintains the rugae—the small folds in the vaginal wall that allow for stretching during intercourse. Furthermore, estrogen plays a critical role in maintaining the vaginal microbiome. It stimulates the production of glycogen in the vaginal cells; when these cells shed, the glycogen is consumed by beneficial bacteria (Lactobacilli), which produce lactic acid. This process maintains a low, acidic pH (typically 3.5 to 4.5), which protects the area from infection.

As estrogen levels drop during perimenopause and postmenopause, this entire system is disrupted. The biological hallmark of this shift is the thinning of the squamous epithelium. The cells that make up the vaginal lining become less robust, and the underlying connective tissue loses its elasticity. This thinning is often accompanied by a reduction in blood flow (ischemia) to the vaginal tissues, which further diminishes the production of lubricating fluids. Clinically, this is observed as a loss of the rugae, leaving the vaginal walls looking pale and smooth rather than pink and folded.

The impact also extends to the chemical environment of the vagina. Without estrogen to fuel glycogen production, the population of Lactobacilli declines, and the vaginal pH rises toward a more neutral or alkaline state. This shift in pH can lead to a change in the microbiome, increasing the risk of bacterial overgrowth and urinary tract infections (UTIs). The combination of thin, fragile tissue and a higher pH makes the area significantly more prone to irritation, micro-tearing, and inflammation.

For many women, these biological changes translate into significant physical discomfort. Vaginal dryness is often accompanied by itching, burning, and a general sensation of irritation. One of the most disruptive aspects is dyspareunia, or painful intercourse. Because the tissue is thin and lacks sufficient lubrication, friction can cause micro-abrasions and intense discomfort, which often leads to a secondary decline in libido and a "vicious cycle" of sexual dysfunction.

From a clinical perspective, these symptoms are now categorized under the umbrella term Genitourinary Syndrome of Menopause (GSM). This term was introduced by the International Society for the Study of Women's Sexual Health and the North American Menopause Society to emphasize that estrogen loss affects the vulva, vagina, and the entire urinary tract simultaneously.

Management of vaginal dryness typically follows a "step-wise" approach. For mild symptoms, over-the-counter vaginal moisturizers (which improve tissue hydration) and lubricants (which reduce friction during activity) may be sufficient. However, for moderate to severe symptoms, local vaginal estrogen therapy is considered the gold standard. Local estrogen—delivered via creams, rings, or tablets—has very low systemic absorption, meaning it treats the local tissue without significantly raising hormone levels in the rest of the body. By restoring the thickness and health of the vaginal lining and normalizing the pH, local estrogen effectively reverses the underlying biological changes.

Key Terms

Related Questions

Compare

Evidence Briefs